Genmab A/S (NASDAQ:GMAB) Q1 2023 Earnings Call Transcript May 10, 2023
Genmab A/S misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $0.65.
Operator: Hello, and welcome to the Genmab’s First Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded. During this telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may...
